Tilray Launches New Medical Strains In Australia
Tilray Medical, a key division of Tilray Brands (NASDAQ: TLRY and TSX: TLRY), continues its global expansion by launching Redecan, an EU-GMP certified medical cannabis brand, in Australia. As a leader in medical cannabis, Tilray is on a mission to empower both patients and healthcare practitioners to make informed therapeutic decisions, and this move marks another big milestone for the company.
Denise Faltischek, Tilray’s Chief Strategy Officer, put it bluntly: “The launch of Redecan in Australia is a significant step in making high-quality medical cannabis accessible worldwide.” And she’s not exaggerating—Tilray already has a strong foothold in the Australian market with its Tilray and Broken Coast offerings. Adding Redecan just further cements their place as a top contender in the medical cannabis world.
Jonathan Trodden, Director of Tilray Medical Australia, chimed in, highlighting that the Redecan launch strengthens their commitment to providing patients with a consistent, premium supply of medical cannabis. In other words, if you’re in Australia and looking for top-shelf cannabis products, Tilray has you covered.
The new Redecan products now available to patients in Australia include:
- Redecan PC THC28 Purple Churro – 15g
- Redecan SA THC28 Space Age Cake – 15g
These new offerings are part of Tilray’s broader mission to deliver EU-GMP certified medical cannabis to patients, physicians, hospitals, and researchers around the globe. Currently, Tilray boasts an impressive portfolio of THC and CBD products available in over 20 countries, supporting trials for everything from fibromyalgia to pediatric epilepsy and even cancer-induced nausea.
Tilray Medical has come a long way from its early days as one of Canada’s first licensed producers. Now, it’s a global giant, offering medical cannabis across five continents, from Portugal to Australia. Whether it’s Redecan or any of its other trusted brands like Aphria and Broken Coast, Tilray remains a dominant force in the growing global cannabis industry.
It’s clear: Tilray isn’t just riding the wave of cannabis legalization—it’s helping to steer the ship.
